Insight: Novo Nordisk fights to keep Medicaid paying for weight-loss drugs

Novo Nordisk, which lobbied to win Medicaid reimbursement for its obesity drug Wegovy, is fighting to keep that coverage as some U.S. states struggle with the treatment's costs, according to state doc... ...